A strong finish saw the S&P/ASX 200 index bounce back from a selloff a week earlier to record a solid gain last week. The benchmark index ended it 1.4% higher than where it started at 6606.8 points.
Whilst the majority of shares on the index pushed higher, some climbed more than most. Here’s why these were the best performers on the S&P/ASX 200 index last week:
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price was the best performer on the S&P/ASX 200 index with a gain of 41.4%. Investors were scrambling to buy the biopharmaceutical company’s shares last week when it provided an update on its SCENESSE product. According to the release, the U.S. FDA has approved the product for the treatment of Erythropoietic protoporphyria (EPP) in adults in the United States. As no other product has approval in the country, this is expected to be a major boost to its sales in 2020.
The Polynovo Ltd (ASX: PNV) share price was some way behind as the next best performer with an 18% gain. Its shares raced higher last week despite there being no news out of the medical device company. However, I suspect increasing investor interest in the biotech and healthcare sectors following Clinuvel’s success may have been the driver of this gain.
The Silver Lake Resources Limited (ASX: SLR) share price was on form last week and recorded an 11.9% gain. Investors were buying the gold miner’s shares after it released a strong first quarter update. During the quarter Silver Lake produced 61,929 ounces of gold equivalent at an all-in sustaining cost of A$1,260 per ounce. In addition to this, the miner revealed that it sold 56,683 ounces of gold and 613 tonnes of copper during the quarter for an average price of A$1,995 per ounce. This means the company is on course to achieve the high end of its sales guidance in FY 2020.
The Orora Ltd (ASX: ORA) share price raced 9.3% higher last week. The packaging company’s shares stormed higher after it announced plans to sell its Australasian Fibre Business to Nippon Paper Industries for ~$1.7 billion. Management advised that the majority of the proceeds of the sale (~$1.2 billion) will be returned to shareholders through capital management initiatives. This appears likely to be a combination of share buybacks and dividends.
The post These were the best-performing shares on the ASX 200 last week appeared first on Motley Fool Australia.
If you missed out on these gains, don't worry. Because these hot stocks have been tipped to be the next ones to race higher.
You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.
So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!
Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...
While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...
Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.
You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019